期刊文献+

新辅助化疗对胃癌微卫星不稳定性的影响 被引量:5

Influence of Neoadjuvant Chemotherapy on Microsatellite Instability in Gastric Carcinoma
下载PDF
导出
摘要 背景与目的:多数胃癌新辅助化疗的临床试验结果是肯定的,而微卫星不稳定性(microsatelliteinstability,MSI)已被认为是细胞癌变的新机理。本文拟探讨新辅助化疗对胃癌MSI的影响。方法:选取D2S123、D3S1298两个微卫星位点,从48例已行氟尿嘧啶/醛氢叶酸(5-FU/CF)术前化疗胃癌患者的石蜡标本中提取DNA,经PCR扩增、变性聚丙烯酰胺凝胶电泳、银盐染色,采用自身对照的方法,比较化疗前后胃癌组织MSI的表现;采用!2检验分析新辅助化疗对胃癌MSI的影响。结果:术前标本两个位点共检出MSI阳性15例,检出率31.3%。术后标本检出MSI阳性6例,检出率为12.5%。共有9例样本由化疗前的MSI阳性变为MSI阴性,无MSI阴性转为MSI阳性的病例。经!2检验,化疗前后的MSI阳性率有显著性差异(31.3%vs.12.5%,P=0.026)。结论:5-FU/CF新辅助化疗方案对胃癌MSI有影响。新辅助化疗后,部分MSI阳性的病例可以表现为阴性,但对MSI阴性病例无影响。 BACKGROUND & OBJECTIVE: Most results from clinical trials of neoadjuvant chemotherapy for gastric carcinoma are certain. Meanwhile, microsatellite instability (MSI) is thought to be a new mechanism of cell canceration. This study was to investigate the influence of neoadjuvant chemotherapy on MSI in gastric carcinoma. METHODS: Two microsatellite loci D2S123 and D3S1298 in tumor samples from 48 patients with gastric carcinoma, received preoperative chemotherapy of 5-fluorouracil (5-FU) and leucovorin (CF), were analyzed by polymerase chain reaction (PCR), electrophoresis on 8% denatured polyacrylamide gel, and silver staining. The microsatellite statuses of preoperative and postoperative specimens were compared. Chi-square test was used to analyze the influence of neoadjuvant chemotherapy on MSI in gastric carcinoma. RESULTS: The detection rate of MSI was significantly higher in preoperative samples than in postoperative samples (31.3% vs. 12.5%, P=0.026). After neoadjuvant chemotherapy, 9 cases changed from MSI-positive to MSI-negative, while no MSI-negative cases became MSI-positive. CONCLUSION: The neoadjuvant chemotherapy regimen of 5-FU/CF can induce some MSI-positive gastric carcinoma change to MSI- negative, but has no effect on MSI-negative cases.
出处 《癌症》 SCIE CAS CSCD 北大核心 2006年第12期1493-1496,共4页 Chinese Journal of Cancer
关键词 胃肿瘤/药物疗法 胃肿瘤/外科手术 DNA 微卫星不稳定性 Gastric neoptasm/chemotherapy Gastric neoplasm/surgical operation DNA Microsatellite instability
  • 相关文献

参考文献11

  • 1Shimada K,Ajani J A.Adjuvant therapy for gastric carcinoma patients in the past 15 years[J].Cancer,1999,86(9):1657-1668.
  • 2Moehler M,Schimanski C C,Gockel I,et al.(Neo)adjuvant strategies of advanced gastric carcinoma:time for a change?[J].Dig Dis,2004,22(4):345-350.
  • 3Tanaka K,Konishi N,Ohmori Y,et al.Modified pharrnacokinetic modulating chemotherapy using 5-fluorouracil,UFT,and taxotere (docetaxel) for advanced gastric cancer[J].Iht J Clin Oncol,2003,8(6):381-385.
  • 4詹友庆,徐立,孙晓卫,仲坚,李威.新辅助化疗对乳腺癌细胞凋亡和增殖的影响[J].癌症,2002,21(2):186-188. 被引量:17
  • 5顾马林,张华,廖美琳,赵明,周瑾,许凯黎.术前化疗对期NSCLC基因变异的作用及其临床意义[J].肿瘤,2000,20(5):385-387. 被引量:2
  • 6张建军,安倩,高燕宁,程书钧.微卫星与肿瘤[J].癌症,2000,19(10):948-950. 被引量:3
  • 7Cravo M L,Albuquerque C M,Salazar de Sousa L,et al.Microsatellite instability in non-neoplastic mucosa of patients with ulcerative colitis:effect of folate supplementation[J].Am J Gastroenterol,1998,93 (11):2060-2064.
  • 8Hashem V I,Pytlos M J,Klysik E A,et al.Chemotherapeutic deletion of CTG repeats in lymphoblast cells from DM1 patients[J].Nucleic Acids Res,2004,32(21):6334-6346.
  • 9Gomes-Pereira M,Monckton D G.Chemically induced increases and decreases in the rate of expansion of a CAG * CTG triplet repeat[J].Nucleic Acids Res,2004,32(9):2865-2872.
  • 10Parker W B,Cheug Y C.Metabolism and mechanism of action of 5-fiuorouracil[J].Pharmacol Ther,1990,48(3):381-395.

二级参考文献10

  • 1周晓东.微卫星不稳定性与肿瘤[J].国外医学(肿瘤学分册),1996,23(4):212-215. 被引量:2
  • 2许凯黎.分子生物学在肺癌临床应用的前景[J].中华医学杂志,1996,76(11):807-808. 被引量:4
  • 3[1]Hickman.Apoptosis induced by anticancer drugs [J].Cancer Metastasis Rev,1992,11: 121- 139.
  • 4[2]Meyn RE,Stephens LC,Hunter NR,et al.Induction of apoptosis in murine tumor by cyclophosphamide [J].Cancer Chemother Pharmacol,1994,33: 410- 414.
  • 5[3]Magno WB,Hirschfield L,Bhuiya T,et al.Correlation of proliferative index (PCNA reactivity and Ki- 67 reactivity) in primary breast carcinoma with hormore status,lymph node status and disease- free survival [J].Conn Med,1992,56(12): 667- 672.
  • 6[4]Tahan SR,Neuberg DS,Dieffenbach A,et al.Prediction of early relapse and shorten survival in patients with breast cancer by proliferation cell nuclear antigen score [J].Cancer,1993,71: 3552- 3559.
  • 7[5]Ellis PA,Smith IE,Detre S,et al.Reduced apoptosis and proliferation and increased Bcl- 2 in residual breast cancer following preoperative chemotherapy [J].Breast Cancer Res Treat,1998,48: 107- 116.
  • 8[6]Bhalla K,Harris WB.Molecular and biologic determinants of neoadjuvant chemotherapy of locoregional breast cancer [J].Semin Onco,1998,252(Suppl 3): 19- 24.
  • 9林震琼,肺癌现代治疗,1998年,153页
  • 10Xu K L,J Gent Mol Biol,1996年,7卷,4期,61页

共引文献19

同被引文献36

  • 1Marisa C Alvarez,Juliana C Santos,Nathália Maniezzo,Marcelo S Ladeira,Artur LC da Silva,Isabel CA Scaletsky,José Pedrazzoli Jr,Marcelo L Ribeiro.MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults[J].World Journal of Gastroenterology,2013,19(20):3043-3051. 被引量:5
  • 2Cunningham D,Allum WH,Stenning SP,菅鑫妍.手术期间化学疗法与单独手术治疗可切除的胃食管癌疗效比较[J].中国处方药,2006,5(8):59-60. 被引量:435
  • 3帅磊渊,王子卫.介入化疗在进展期胃癌新辅助化疗中的应用现状[J].医学综述,2007,13(13):993-996. 被引量:6
  • 4周东雷.FOLFOX7新辅助化疗对进展期胃癌治疗策略的影响[D].广州:第二军医大学,2012.
  • 5杨酷,王治国.多西他赛联合顺铂、氟尿嘧啶和亚叶酸钙的新辅助化疗方案治疗不能切除进展期胃癌的疗效观察[J].中国医学创新,2011,8(33):46-50.
  • 6Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2005: GLOBOCAN 2008 [J]. Int J Cancer, 2010,127 ( 12 ) :2893-2917.
  • 7Sutton JM,Abbott DE. Neoadjuvant therapy for pancreas cancer: past lessons and future therapies[ J]. World J Gastroentero12014, 20(42) :15564-15579.
  • 8Teshome M, Hunt KK. Neoadjuvant Therapy in the Treatment of Breast Cancer[ J]. Surg Oncol Clin N Am,2014,23 (3):505- 523.
  • 9Horgan AM, Amir E, Walter T, et al. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-a- nalysis [ J]. J Clin Oncol,2012,30( 16 ) : 1934-1940.
  • 10Ashoori N, Paprottka P, Trumm C, et al. Multimodality treatment with conventional transcatheter arterial chemoem, holization and radiofrequency ablation for unresectable hepatocellular carcinoma [J]. Digestion ,2012,85( 1 ) :18.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部